Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.
about
Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formationThrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overloadHematopoietic Id Deletion Triggers Endomyocardial Fibrotic and Vascular Defects in the Adult Heart.Natural angiogenesis inhibitor signals through Erk5 activation of peroxisome proliferator-activated receptor gamma (PPARgamma).Structural ECM components in the premetastatic and metastatic niche.Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyEPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1.Quantitative proteomics reveals differential regulation of protein expression in recipient myocardium after trilineage cardiovascular cell transplantation.Maturational regression of glomeruli determines the nephron population in normal micePregnancy-associated genes contribute to antiluteolytic mechanisms in ovine corpus luteum.Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.Antiangiogenic and anticancer molecules in cartilage.Thrombospondins, potential drug targets for cardiovascular diseases.Metamorphosis in solitary ascidians.miR-200a modulate HUVECs viability and migration.Aureobasidium pullulans produced β-glucan is effective to enhance Kurosengoku soybean extract induced Thrombospondin-1 expression.Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.Thrombospondins: A Role in Cardiovascular Disease.Thrombospondins function as regulators of angiogenesis.[Role of thrombospondin-1 in the development of kidney diseases].Stimulation of synapse formation between stem cell-derived neurons and native brainstem auditory neurons.Predictive model identifies strategies to enhance TSP1-mediated apoptosis signaling.The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis.Apigenin Inhibits UVB-Induced Skin Carcinogenesis: The Role of Thrombospondin-1 as an Anti-Inflammatory Factor
P2860
Q24306115-40FF6F05-A663-4B4C-B32E-F1D1358E15B8Q28507674-42BA67A6-BF97-4FA5-93FF-1842FBCECD32Q33780050-15537819-C96D-4F7E-923C-ED22D4A907DDQ33809978-559F1EF6-5CBC-49D5-A164-35DBB0BF40AAQ34521147-BDA1F796-6574-4B60-97DF-2267DACA647FQ35078258-358C5F8B-8B2A-49AE-9C4D-2E8470A09639Q35238478-6FA5B215-8178-448F-9177-C8DAEB12F6BBQ35315207-7E6AA42E-4C40-4792-AF9B-A5D2F9D9A510Q35902676-C2FE3D95-19C8-49A2-8A76-2BB4553B8E90Q36282739-1EADEE1E-6F34-4BA6-8D65-71980A1DAD82Q36403046-11813659-64AA-4F1B-8CCF-FB91E47DE363Q36707422-BD3B041F-6867-443E-8744-AD850873FA9CQ37346020-3FFF53B0-C996-4059-B7C4-EB6F4C33A01FQ37899674-AECD2151-58E5-4C21-8D82-C8EC50B10A50Q37963916-6876A0C1-FF1E-4C3A-9422-70C7F4CE2A42Q38007565-F344D2AB-9389-4457-A5BC-DA9F62E5FA88Q38052913-6F306C23-A831-4131-8DA2-24846EDF89D5Q38253773-617BB6C3-BA41-4CED-925A-9E350E88457EQ38334026-CDFFC4C6-81B5-455F-8D8C-EE1C9CB0A451Q38701048-2B3163F5-0A03-4128-9641-E3095F89F737Q39220891-16DC697A-00C5-441F-9A6D-4C56322CD687Q39438819-6C1A2E5C-05F6-49E3-B818-44992E1EFADEQ42643939-B2419910-3AE7-4596-8B78-065F51651D79Q43554936-39040F3D-4418-481B-9986-578ED8D91495Q47171795-5884C9B2-D2CC-4C0B-B5D3-19DA05DC2C65Q47234112-38F3AD38-FE99-4232-8AE2-3C1F393FFFF4Q48298658-71B02175-C755-4436-8857-23706AF0F4EDQ50019794-5B17C020-80CA-43E5-B876-34276FEA37BCQ55450211-74292911-DB20-4B1E-BA07-7744F2F5014BQ58777810-14E4CC56-8515-4E49-9D05-3674608C9957
P2860
Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thrombospondin and apoptosis: ...... of complementation treatments.
@en
Thrombospondin and apoptosis: ...... of complementation treatments.
@nl
type
label
Thrombospondin and apoptosis: ...... of complementation treatments.
@en
Thrombospondin and apoptosis: ...... of complementation treatments.
@nl
prefLabel
Thrombospondin and apoptosis: ...... of complementation treatments.
@en
Thrombospondin and apoptosis: ...... of complementation treatments.
@nl
P2093
P2860
P1433
P1476
Thrombospondin and apoptosis: ...... of complementation treatments.
@en
P2093
O V Volpert
Y Mirochnik
P2860
P304
P356
10.2174/138945008785909347
P577
2008-10-01T00:00:00Z